BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32133363)

  • 1. Insights Into the Characteristics of Sweet Syndrome in Patients With and Without Hematologic Malignancy.
    Zheng S; Li S; Tang S; Pan Y; Ding Y; Qiao J; Fang H
    Front Med (Lausanne); 2020; 7():20. PubMed ID: 32133363
    [No Abstract]   [Full Text] [Related]  

  • 2. Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients.
    Rochet NM; Chavan RN; Cappel MA; Wada DA; Gibson LE
    J Am Acad Dermatol; 2013 Oct; 69(4):557-64. PubMed ID: 23891394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral center.
    Nelson CA; Noe MH; McMahon CM; Gowda A; Wu B; Ashchyan HJ; Perl AE; James WD; Micheletti RG; Rosenbach M
    J Am Acad Dermatol; 2018 Feb; 78(2):303-309.e4. PubMed ID: 29107342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Sweet syndrome in patients with or without malignancy.
    Jung EH; Park JH; Hwan Kim K; Kim JS; Sil Choi I; Byun JM; Koh Y; Shin DY; Hong J; Yoon SS; Park H; Kim I
    Ann Hematol; 2022 Jul; 101(7):1499-1508. PubMed ID: 35482090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sweet Syndrome: Clinical Presentation, Malignancy Association, Autoinflammatory Disorders and Treatment Response in a Cohort of 93 Patients with Long-term Follow-up.
    Gil-Lianes J; Luque-Luna M; Alamon-Reig F; Bosch-Amate X; Serra-Garcia L; Mascaró JM
    Acta Derm Venereol; 2023 Dec; 103():adv18284. PubMed ID: 38112209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sweet syndrome in patients with solid tumors.
    Cohen PR; Holder WR; Tucker SB; Kono S; Kurzrock R
    Cancer; 1993 Nov; 72(9):2723-31. PubMed ID: 8402496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sweet Syndrome Associated with Myelodysplastic Syndrome-A Review of a Multidisciplinary Approach.
    Ferea CR; Mihai SN; Balan G; Badescu MC; Tutunaru D; Tatu AL
    Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Rare Case of Drug-Induced Sweet Syndrome After Pembrolizumab Therapy.
    Muralidharan S; Mariano AT; Joshi D; Andrews TE; Liu S; Basha A; Huynh N
    Cureus; 2024 Jun; 16(6):e62027. PubMed ID: 38859947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sweet Syndrome: Clinical Features, Histopathology, and Associations of 83 Cases.
    Casarin Costa JR; Virgens AR; de Oliveira Mestre L; Dias NF; Samorano LP; Valente NYS; Festa Neto C
    J Cutan Med Surg; 2017; 21(3):211-216. PubMed ID: 28300447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Features of Neutrophilic Dermatosis Variants Resembling Necrotizing Fasciitis.
    Sanchez IM; Lowenstein S; Johnson KA; Babik J; Haag C; Keller JJ; Ortega-Loayza AG; Cohen J; McCalmont TH; Demer AM; Mansh MD; Hylwa SA; Liu J; Shinkai K
    JAMA Dermatol; 2019 Jan; 155(1):79-84. PubMed ID: 30383110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Acute Myeloid Leukemia-Associated Necrotizing Sweet Syndrome.
    Strong J; Zhou AE; Alkaabba F; Soldin D; Moon J; Alharthy H; Syed O; Liu Y; Turney K; Markidan J; Malone L; Lee ST; DeRosa P
    Case Rep Dermatol; 2022; 14(3):339-343. PubMed ID: 36466752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Sweet Syndrome in patients with acute myeloid leukemia.
    Kazmi SM; Pemmaraju N; Patel KP; Cohen PR; Daver N; Tran KM; Ravandi F; Duvic M; Garcia-Manero G; Pierce S; Nazha A; Borthakur G; Kantarjian H; Cortes J
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):358-363. PubMed ID: 25630528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent Malignancy-Associated Atypical Neutrophilic Dermatosis With Noninfectious Shock.
    Kinser KN; Panach K; Dominguez AR
    Am J Med Sci; 2017 Dec; 354(6):626-632. PubMed ID: 29208261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic, Immunohistochemical, and Molecular Features of Histiocytoid Sweet Syndrome.
    Alegría-Landa V; Rodríguez-Pinilla SM; Santos-Briz A; Rodríguez-Peralto JL; Alegre V; Cerroni L; Kutzner H; Requena L
    JAMA Dermatol; 2017 Jul; 153(7):651-659. PubMed ID: 28296991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histiocytoid Sweet syndrome may indicate leukemia cutis: a novel application of fluorescence in situ hybridization.
    Chavan RN; Cappel MA; Ketterling RP; Wada DA; Rochet NM; Knudson R; Gibson LE
    J Am Acad Dermatol; 2014 Jun; 70(6):1021-7. PubMed ID: 24636890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sweet syndrome associated with myelodysplastic syndrome: report of a case. Review of the literature.
    Reina D; Cerdà D; Roig D; Fíguls R; Villegas ML; Corominas H
    Reumatol Clin; 2013; 9(4):246-7. PubMed ID: 22749728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panniculitis in a 3-year-old child with Fanconi anemia-associated bone marrow hypoplasia heralds transformation to acute myeloid leukemia.
    Webber L; Cummins M; Mann R; Shaw L; Ghinai R; Mahon C
    Pediatr Dermatol; 2019 Sep; 36(5):725-727. PubMed ID: 31318095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant Renal Cell Carcinoma and Hematologic Malignancy in Immunosuppressed Patients.
    Johnson L; Bylund J; Strup S; Howard D; Gul Z; Khan MW; Venkatesh R
    Am J Med Sci; 2016 May; 351(5):480-4. PubMed ID: 27140706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sweet's syndrome: a review of current treatment options.
    Cohen PR; Kurzrock R
    Am J Clin Dermatol; 2002; 3(2):117-31. PubMed ID: 11893223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.